Michael Egholm

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael Egholm by Tomone Tanaka, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael Egholm

Form 4 holding President & CEO, Director

STANDARD BIOTOOLS INC.

Security class
Stock Option (Right to buy)
Shares / value
2,345,340
Estimated value
$6,666,550
Report date
20 Mar 2026
Price
$3.74
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President & CEO, Director

STANDARD BIOTOOLS INC.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$210,269
Report date
06 Apr 2026
Price
$1.07
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IsoPlexis Corp

Security class
Stock Option
Shares / value
89,047
Estimated value
Report date
16 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael Egholm

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .